Innova Captab Limited Board Approves Re-appointments of Auditors and Key Directors
Innova Captab Limited announced the outcomes of its Board of Directors meeting held on May 25, 2026. The Board approved the re-appointment of statutory, cost, and internal auditors, along with the re-appointment of key managerial personnel and several Non-Executive Independent Directors (NEIDs) for subsequent terms.The board meeting included detailed consideration of several corporate governance matters, concluding with the approval of notice for the company's 22nd Annual General Meeting (AGM) for the financial year ended March 31, 2026.
Audit and Statutory Appointments
The Board approved the re-appointment of three major auditing firms for various financial years:| Role | Firm Name | Re-appointment Term | Financial Year(s) |
|---|---|---|---|
| Statutory Auditor | M/s. B S R & Co. LLP, Chartered Accountants | Second term of five consecutive years | 2026-27 to 2030-31 |
| Cost Auditor | M/s. Gurvinder Chopra and Co., Cost Accountants | One year | 2026-27 |
| Internal Auditor | M/s. Grant Thornton Bharat LLP, Chartered Accountants | One year | 2026-27 |
Key Management Director Re-appointments
The Board recommended the following re-appointments for senior leadership roles, effective upon member approval at the ensuing AGM:- Mr. Manoj Kumar Lohariwala (DIN: 00144656) was approved for re-appointment as Whole-Time Director for a second term of five consecutive years, effective from March 18, 2027, up to March 17, 2032. Mr. Lohariwala possesses over 29 years of experience in manufacturing and marketing of pharmaceutical products and is the brother of the Managing Director.
- Mr. Vinay Lohariwala (DIN: 00144700) was approved for re-appointment as Managing Director for a second term of five consecutive years, effective from March 18, 2027, up to March 17, 2032. Mr. Lohariwala has over 24 years of experience in manufacturing and marketing pharmaceutical products and is the brother of the Whole-Time Director.
Non-Executive Independent Directors
The Board also approved the re-appointment of four individuals as Non-Executive Independent Directors, all subject to member approval at the Annual General Meeting.| Director Name | DIN | Period of Appointment | Experience Highlights |
|---|---|---|---|
| Mr. Sudhir Kumar Bassi | 07819617 | April 1, 2027 to March 31, 2032 | Over 34 years in investment banking and capital markets. |
| Ms. Priyanka Dixit | 06578720 | April 1, 2027 to March 31, 2032 | Over 14 years in corporate commercial law and mergers and acquisitions. |
| Mr. Mahendar Korthiwada | 09558992 | April 1, 2027 to March 31, 2032 | Over 32 years of experience in the pharmaceutical industry. |
| Mr. Shirish Gundopant Belapure | 02219458 | April 1, 2027 to March 31, 2032 | Over 30 years of experience in the pharmaceutical industry. |
The company confirmed that all the newly appointed independent directors are not related to any Director/Key Managerial Personnel.
The Board also approved the notice for the 22nd Annual General Meeting (AGM) of the Company for the financial year ended March 31, 2026. The notice and Annual Report will be submitted to the Stock Exchange(s) in due course of time.
INNOVACAP Stock Price Movement
On Monday, Innova Captab Limited shares edged higher, closing at ₹855.05 after gaining 0.53%. The stock saw active trading, with the equity settling at a total volume of 85,586 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: